Go to Main Content

SPEAKERS

Become A Speaker

Suzanne McGurn

President & CEO

Canada’s Drug Agency (CDA-AMC)

Dominic Tan

Deputy CEO

pCPA

Guillaume Couillard

Executive Director

Patented Medicine Prices Review Board (PMPRB)

Tijana Fazlagic

Executive Director, Therapeutic Assessment & Access Branch

BC Ministry of Health

Daniel MacDonald

Director General, Drugs for Rare Diseases

Health Canada

Paul Petrelli

Vice President & General Manager

Gilead Sciences Canada

Christian Ouellet

Vice President, Corporate Affairs

Sandoz Canada

Dr. Mina Tadrous

Assistant Professor, Leslie Dan Faculty of Pharmacy, and Investigator - Ontario Drug Policy Research Network

University of Toronto

Dr. Alysha Croker

Director, Strategic and Horizontal Policy Division Health Products and Food Branch

Health Canada

Simona Zar

SVP, Government Relations

CAPDM

Sarah Shaikho

Director, National Stakeholder Engagement

Celltrion Healthcare Canada Limited

Chris Réaume

Medical Director, Canada – Neurosciences

Eisai Canada

Arima Ventin

Head of Market Access & Government Affairs

AbbVie

Brandon Levac

Head of Market Access and Government Affairs

Bayer Inc

Gail Ouellette

Geneticist/Genetic Counsellor & Director

Canadian iRARE Centres

Chander Sehgal

Head of Access, Pricing, & External Engagement (APEX)

UCB Canada

Kim Steele

Director, Government & Community Relations

Cystic Fibrosis Canada

Sam Stankovic

Head of Market Access, Canada

Incyte Pharmaceuticals

Carol Stiff

General Manager Canada

Rhythm Therapeutics

Anie Perrault

Chairperson

Patented Medicine Prices Review Board (PMPRB)

Mélanie Caron

Director, Directorate for the Evaluation of Medicines and Technologies for Reimbursement Purposes

Institut national d'excellence en santé et en services sociaux (INESSS)

BECOME A SPEAKER

This is your chance to showcase your expertise and connect with key industry stakeholders!

Become A Speaker